Acute bacterial prostatitis
ICD-10 N41.0 · ICD-11 GA91.Y.1

Evidence-Based Treatment for Acute Bacterial Prostatitis

Overview

Acute bacterial prostatitis requires prompt initiation of effective antimicrobial therapy to achieve infection control and symptom resolution. The structured protocol defines the recommended approach, including parenteral initiation and the criteria for transitioning to oral management.

Treatment Approach

Initial management involves parenteral administration of high-dose broad-spectrum antimicrobial therapy, alongside supportive measures — with an oral step-down following normalisation of infection parameters. Full drug selection, combination options, and duration guidance are detailed in the complete protocol.

Clinical Goals
Instant Access to Structured Evidence-Based Regimens

References

  1. In ABP, parenteral administration of high doses of bactericidal antimicrobials, such as broad-spectrum penicillins, a third-generation cephalosporin or fluoroquinolones, is recommended.
  2. For initial therapy, any of these antimicrobials can be combined with an aminoglycoside.
  3. Ancillary measures include adequate fluid intake and urine drainage.
  4. After normalisation of infection parameters, oral therapy can be substituted and continued for a total of two to four weeks.
View source ↗